Cargando…

Antifungal Drugs

We reviewed the licensed antifungal drugs and summarized their mechanisms of action, pharmacological profiles, and susceptibility to specific fungi. Approved antimycotics inhibit 1,3-β-d-glucan synthase, lanosterol 14-α-demethylase, protein, and deoxyribonucleic acid biosynthesis, or sequestrate erg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Houšť, Jiří, Spížek, Jaroslav, Havlíček, Vladimír
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143493/ https://www.ncbi.nlm.nih.gov/pubmed/32178468 http://dx.doi.org/10.3390/metabo10030106

Ejemplares similares

Noninvasive Combined Diagnosis and Monitoring of Aspergillus and Pseudomonas Infections: Proof of Concept
por: Dobiáš, Radim, et al.
Publicado: (2021)

Sources of Antifungal Drugs
por: Vanreppelen, Giel, et al.
Publicado: (2023)

Lincomycin Biosynthesis Involves a Tyrosine Hydroxylating Heme Protein of an Unusual Enzyme Family
por: Novotna, Jitka, et al.
Publicado: (2013)

Use of antifungal drugs in hematology
por: Nucci, Marcio
Publicado: (2012)

Susceptibility Testing of Fungi to Antifungal Drugs
por: Sanguinetti, Maurizio, et al.
Publicado: (2018)

Epigenetic Regulation of Antifungal Drug Resistance
por: Patra, Sandip, et al.
Publicado: (2022)

Repurposing antifungal drugs for cancer therapy
por: Weng, Ningna, et al.
Publicado: (2022)

Antifungal Drug Resistance: An Emergent Health Threat
por: Vitiello, Antonio, et al.
Publicado: (2023)

The Microevolution of Antifungal Drug Resistance in Pathogenic Fungi
por: Boyce, Kylie J.
Publicado: (2023)

Increased incidence of traffic accidents in Toxoplasma-infected military drivers and protective effect RhD molecule revealed by a large-scale prospective cohort study
por: Flegr, Jaroslav, et al.
Publicado: (2009)

Antifungal Drug Development: Targeting the Fungal Sphingolipid Pathway
por: McEvoy, Kyle, et al.
Publicado: (2020)

Host Defense Peptides as Templates for Antifungal Drug Development
por: Basso, Virginia, et al.
Publicado: (2020)

An insight into new strategies to combat antifungal drug resistance
por: Zheng, Yan-Hua, et al.
Publicado: (2018)

Augmenting Azoles with Drug Synergy to Expand the Antifungal Toolbox
por: Kane, Aidan, et al.
Publicado: (2022)

Antifungal Drug Repurposing
por: Kim, Jong H., et al.
Publicado: (2020)

Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients
por: Bellmann, Romuald, et al.
Publicado: (2017)

Therapeutic tools for oral candidiasis: Current and new antifungal drugs
por: Quindós, Guillermo, et al.
Publicado: (2019)

Advances in Antifungal Drug Development: An Up-To-Date Mini Review
por: Bouz, Ghada, et al.
Publicado: (2021)

Solid lipid nanoparticles, an effective carrier for classical antifungal drugs
por: Almawash, Saud
Publicado: (2023)

Emerging Polymer-Based Nanosystem Strategies in the Delivery of Antifungal Drugs
por: Xin, Yuan, et al.
Publicado: (2023)

Current applications and prospects of nanoparticles for antifungal drug delivery
por: Nami, Sanam, et al.
Publicado: (2021)

Drug repurposing strategies in the development of potential antifungal agents
por: Zhang, Qian, et al.
Publicado: (2021)

Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi
por: Parente-Rocha, Juliana Alves, et al.
Publicado: (2017)

Antifungal and Antiparasitic Drug Delivery
por: Torrado, Juan José, et al.
Publicado: (2020)

Current and Future Pathways in Aspergillus Diagnosis
por: Dobiáš, Radim, et al.
Publicado: (2023)

Aspiring Antifungals: Review of Current Antifungal Pipeline Developments
por: Gintjee, Thomas J., et al.
Publicado: (2020)

Pathogenesis and Antifungal Drug Resistance of the Human Fungal Pathogen Candida glabrata
por: Tscherner, Michael, et al.
Publicado: (2011)

Responding to the emergence of antifungal drug resistance: perspectives from the bench and the bedside
por: Beardsley, Justin, et al.
Publicado: (2018)

Resurgence and Repurposing of Antifungal Azoles by Transition Metal Coordination for Drug Discovery
por: Cortat, Youri, et al.
Publicado: (2023)

Nanoliposome-loaded antifungal drugs for dermal administration: A review
por: Asadi, Peyman, et al.
Publicado: (2021)

Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery
por: Abdulaziz, Leena, et al.
Publicado: (2022)

Probable neuroimmunological link between Toxoplasma and cytomegalovirus infections and personality changes in the human host
por: Novotná, Martina, et al.
Publicado: (2005)

Novel Pyrazine Analogs of Chalcones: Synthesis and Evaluation of Their Antifungal and Antimycobacterial Activity
por: Kucerova-Chlupacova, Marta, et al.
Publicado: (2015)

Quantitative and Qualitative Analysis of the Antifungal Activity of Allicin Alone and in Combination with Antifungal Drugs
por: Kim, Young-Sun, et al.
Publicado: (2012)

Analysis of the synergistic antifungal activity of everolimus and antifungal drugs against dematiaceous fungi
por: An, Lulu, et al.
Publicado: (2023)

Antifungal Drug-Drug Interactions with Commonly Used Pharmaceutics in European Pediatric Patients with Acute Lymphoblastic Leukemia
por: Sienkiewicz-Oleszkiewicz, Beata, et al.
Publicado: (2023)

Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium
por: Arastehfar, Amir, et al.
Publicado: (2020)

The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida
por: Lewis, Russell E., et al.
Publicado: (2012)

An Invertebrate Host to Study Fungal Infections, Mycotoxins and Antifungal Drugs: Tenebrio molitor
por: Canteri de Souza, Patrícia, et al.
Publicado: (2018)

A Highlight on the Inhibition of Fungal Carbonic Anhydrases as Drug Targets for the Antifungal Armamentarium
por: Supuran, Claudiu T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6vt163rs9cftlvr4fs78dgaj4n